Neurochemical correlates to selective neuronal vulnerability.
Wieloch
T
T
D000241:Adenosine / Q000378:metabolism / Q000502:physiology; D000344:Afferent Pathways / Q000503:physiopathology; D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism; D001927:Brain Diseases / Q000378:metabolism / Q000503:physiopathology*; D002545:Brain Ischemia / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D002118:Calcium / Q000378:metabolism / Q000502:physiology; D002712:Chlorides / Q000378:metabolism / Q000502:physiology; D005971:Glutamates / Q000378:metabolism; D018698:Glutamic Acid; D007003:Hypoglycemia / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D008954:Models, Biological; D009433:Neural Inhibition; D009448:Neurochemistry; D009474:Neurons / Q000378:metabolism / Q000502:physiology*; D018377:Neurotransmitter Agents / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism / Q000502:physiology; D010277:Parasympathomimetics / Q000378:metabolism; D017378:Quinolinic Acid; D011805:Quinolinic Acids / Q000378:metabolism; D051381:Rats; D005680:gamma-Aminobutyric Acid / Q000378:metabolism / Q000502:physiology
D002712:Chlorides; D005971:Glutamates; D018377:Neurotransmitter Agents; D010277:Parasympathomimetics; D011805:Quinolinic Acids; D001224:Aspartic Acid; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D017378:Quinolinic Acid; D000241:Adenosine; D002118:Calcium; D009638:Norepinephrine